Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shlipak

Showing results (311-320 of 738) with videos related to

Pageof 74
Sort By:
BMC Nephrology|November 14, 2023
Associations between abrupt transition, dialysis-requiring AKI, and early mortality in ESKD among U.S. veteransRaymond K Hsu, Anna D Rubinsky, Michael G Shlipak, et al.
Kidney360|March 13, 2024
Association of Urinary Dickkopf-3 Levels with Cardiovascular Events and Kidney Disease Progression in Systolic Blood Pressure Intervention TrialVanessa-Giselle Peschard, Rebecca Scherzer, Ronit Katz, et al.
Journal of the American Society of Nephrology : JASN|December 21, 2013
Urinary biomarkers of AKI and mortality 3 years after cardiac surgerySteven G Coca, Amit X Garg, Heather Thiessen-Philbrook, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 8, 2016
Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rateNatalie Ebert, Pierre Delanaye, Michael Shlipak, et al.
Archives of Internal Medicine|December 14, 2005
Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health StudyAnn M O'Hare, Anne B Newman, Ronit Katz, et al.
Circulation|August 27, 2003
Differences in medical care and disease outcomes among black and white women with heart diseaseAshish K Jha, Paul D Varosy, Alka M Kanaya, et al.
JAMA|April 14, 2005
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factorsMichael G Shlipak, Linda F Fried, Mary Cushman, et al.
JAMA|April 13, 2011
Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortalityCarmen A Peralta, Michael G Shlipak, Suzanne Judd, et al.
Circulation|March 17, 2005
Race and renal impairment in heart failure: mortality in blacks versus whitesGrace L Smith, Michael G Shlipak, Edward P Havranek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2018
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in EldersVasantha Jotwani, Ronit Katz, Joachim H Ix, et al.
Pageof 74

Showing results (311-320 of 738) with videos related to

Sort By:
Pageof 74
BMC Nephrology|November 14, 2023
Associations between abrupt transition, dialysis-requiring AKI, and early mortality in ESKD among U.S. veteransRaymond K Hsu, Anna D Rubinsky, Michael G Shlipak, et al.
Kidney360|March 13, 2024
Association of Urinary Dickkopf-3 Levels with Cardiovascular Events and Kidney Disease Progression in Systolic Blood Pressure Intervention TrialVanessa-Giselle Peschard, Rebecca Scherzer, Ronit Katz, et al.
Journal of the American Society of Nephrology : JASN|December 21, 2013
Urinary biomarkers of AKI and mortality 3 years after cardiac surgerySteven G Coca, Amit X Garg, Heather Thiessen-Philbrook, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 8, 2016
Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rateNatalie Ebert, Pierre Delanaye, Michael Shlipak, et al.
Archives of Internal Medicine|December 14, 2005
Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health StudyAnn M O'Hare, Anne B Newman, Ronit Katz, et al.
Circulation|August 27, 2003
Differences in medical care and disease outcomes among black and white women with heart diseaseAshish K Jha, Paul D Varosy, Alka M Kanaya, et al.
JAMA|April 14, 2005
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factorsMichael G Shlipak, Linda F Fried, Mary Cushman, et al.
JAMA|April 13, 2011
Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortalityCarmen A Peralta, Michael G Shlipak, Suzanne Judd, et al.
Circulation|March 17, 2005
Race and renal impairment in heart failure: mortality in blacks versus whitesGrace L Smith, Michael G Shlipak, Edward P Havranek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2018
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in EldersVasantha Jotwani, Ronit Katz, Joachim H Ix, et al.
Pageof 74